CAPTRUST FINANCIAL ADVISORS

Position in GEHC — GE HealthCare Technologies Inc.

CIK 1512024 RALEIGH, NC

Position in GEHC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,063,582

-$573,075 QoQ

Shares Held

47,861

-6.3% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#278

of 1,219 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 32% Shared 0% None 68%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $194,335,431 across 52 Medical Devices names. GEHC ranks #8 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	509,302	$46,214,063
2	STE	STERIS plc	209,519	$44,118,415
3	SYK	Stryker Corp	138,667	$43,657,918
4	MDT	Medtronic plc	258,603	$20,230,512
5	EW	Edwards Lifesciences Corp	60,926	$5,511,365
6	BSX	Boston Scientific Corp	123,736	$5,281,052
7	DXCM	Dexcom Inc	47,517	$3,200,269
8	GEHC	GE HealthCare Technologies Inc. This page	47,861	$3,063,582

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,063,582	47,861	-6.3%	Shares	Sole	2026-08-13
2026-03-31	$3,636,657	51,091	+27.7%	Shares	Sole	2026-05-15
2025-12-31	$3,281,374	40,007	+7.3%	Shares	Sole	2026-02-17
2025-09-30	$2,801,230	37,300	+13.9%	Shares	Sole	2025-11-19
2025-06-30	$2,426,607	32,761	-5.8%	Shares	Sole	2025-08-15
2025-03-31	$2,805,641	34,762	-4.0%	Shares	Sole	2025-05-15
2024-12-31	$2,831,210	36,214	+8.6%	Shares	Sole	2025-02-14
2024-09-30	$3,130,179	33,353	+1.6%	Shares	Sole	2024-11-14
2024-06-30	$2,557,256	32,819	-0.9%	Shares	Sole	2024-08-15
2024-03-31	$3,011,393	33,125	-27.2%	Shares	Sole	2024-05-15
2023-12-31	$3,516,358	45,478	+3.7%	Shares	Sole	2024-02-14
2023-09-30	$2,984,370	43,862	+56.5%	Shares	Sole	2023-11-15
2023-06-30	$2,277,319	28,032	+2.8%	Shares	Sole	2023-08-15
2023-03-31	$2,237,614	27,278	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.